Tayel, S. A., M. A. El-Nabarawi, M. I. Tadros, and W. H. Abd-Elsalam,
"Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits",
Int J Pharm, vol. 443, issue 1-2, pp. 293-305, 2013.
Teaima, M. H., K. M. Abdel-Haleem, R. Osama, M. A. El-Nabarawi, and O. S. Elnahas,
"A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study",
Drug Design, Development and Therapy, vol. 15, pp. 4229-4242, 2021.
teaima, M., Nabil A. Shoman, Magdi M. Abdel Hamid, B. R. Jasti, and M. A. El-Nabarawi,
"Promising Swellable Floating Bupropion Tablets: Formulation, in vitro/in vivo Evaluation and Comparative Pharmacokinetic Study in Human Volunteers.",
Drug Des Devel Ther. , vol. 14, pp. 2741-2757, 2020.
teaima, M., M. A. M. Hamid, N. A. Shoman, B. R. Jasti, and M. A. El-Nabarawi,
"Promising Swellable Floating Bupropion Tablets: Formulation, in vitro/in vivo Evaluation and Comparative Pharmacokinetic Study in Human Volunteers",
Drug Design, Development and Therapy, vol. 14, pp. 2741-2757, 2020.
Teaima, M. H., M. Yasser, M. A. El-Nabarawi, and D. A. Helal,
"Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits.",
. Drug Des Devel Ther. , vol. 14, pp. 1319–1331, 2020.
Teaima, M. H., M. Yasser, M. A. El-Nabarawi, and D. A. Helal,
"Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits",
Drug Design, Development and Therapy, vol. 14, pp. 1319-1331, 2020.
Teaima, M. H., M. Yasser, M. A. El-Nabarawi, and D. A. Helal,
"Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits",
Drug Design, Development and Therapy, vol. 14, pp. 1319-1331, 2020.
Teaima, M. H., A. Al‑Nuseirat, Dalia Abouhussein, O. A. Badary, and M. A. El‑Nabarawi,
"Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study",
Journal of Pharmaceutical Policy and Practice, vol. 14, pp. 106, 2021.
Tealab, S., N. Sedhom, and A. Hassouna,
"Prevalence of human papilloma virus in oropharyngeal, tongue and lip squamous cell carcinoma: an experience from the Egyptian National Cancer Institute",
J Investig Med, vol. 67, issue 7, pp. 1061-1066, 2019.
Teklu, S., A. H. Soliman, and A. El-Zawahry,
"Planning for Environmental Water Allocations: Hydrology - Based Assessment in the Awash River Basin, Ethiopia",
Journal of Environment and Earth Science, vol. 9, issue 11, pp. 78-87, 2019.
Terakawa, T., A. A. Hussein, Y. Bando, K. A. Guru, J. Furukawa, K. Shigemura, K. Harada, N. Hinata, Y. Nakano, and M. Fujisawa,
"Presurgical pazopanib for renal cell carcinoma with inferior vena caval thrombus: a single-institution study.",
Anti-cancer drugs, vol. 29, issue 6, pp. 565-571, 2018 Jul.
AbstractThe aim of this study was to investigate the clinical benefit of presurgical therapy with pazopanib in renal cell carcinoma (RCC) patients with a tumor thrombus extending to a high level in the vena cava. A retrospective review was performed for seven consecutive patients with RCC and tumor thrombus involving the vena cava above the hepatic vein (level 3-4, Mayo Clinic classification) treated with pazopanib without initial cytoreductive nephrectomy at our institution. The effect of pazopanib was assessed in terms of the primary site response, thrombus diameter, and height (before and after treatment) on computed tomography or MRI. The tumor thrombus level before the induction of pazopanib was 3 in one patient and 4 in the remaining six patients. After pazopanib, shrinkage of the primary site and thrombus diameter and length were observed in all patients except one (with a rhabdoid tumor). The mean decreases of primary tumor diameter, tumor thrombus diameter, and length were 14, 9, and 31 mm, respectively. The tumor thrombus level decreased in three (43%) patients and remained stable in the remaining patient. Our findings suggest that presurgical treatment with pazopanib may shrink the tumor thrombus and decrease the surgical invasiveness in RCC patients with a high-level tumor thrombus.
Thabet, O. E. M., W. S. Mohamed, M. Assem, A. R. A. Hamid, and R. A. Osman,
"Prognostic Value of Soluble HLA-G and CD38 Expression in Patients with Chronic Lymphocytic Leukemia in Egypt",
Egyptian journal of hospital medicine, vol. Volume 80, issue Issue 1, pp. Page 581-586, 2020.
Thraeib, J. Z., A. B. Altemimi, A. J. A. Al-Manhel, T. G. Abedelmaksoud, A. A. A. El-Maksoud, C. S. Madankar, and F. Cacciola,
"Production and characterization of a bioemulsifier derived from microorganisms with potential application in the food industry",
Life, vol. 12, issue 6, pp. 924, 2022.
Tijjani, H., A. P. Adegunloye, A. Uba, J. O. Adebayo, G. A. Gyebi, and I. M. Ibrahim,
"Pharmacoinformatic study of inhibitory potentials of selected flavonoids against papain-like protease and 3-chymotrypsin-like protease of SARS-CoV-2",
Clinical Phytoscience, vol. 8, issue 16, 2022.